H.R. 4384 (112th): Patient Safety and Drug Labeling Improvement Act


Apr 18, 2012
112th Congress, 2011–2013

Died in a previous Congress

This bill was introduced on April 18, 2012, in a previous session of Congress, but was not enacted.


Chris Van Hollen Jr.

Representative for Maryland's 8th congressional district



Read Text »
Last Updated: Apr 18, 2012
Length: 2 pages

About the bill

Full Title

To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.

Summary (CRS)

4/18/2012--Introduced.Patient Safety and Drug Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) ... Read more >

The bill’s title was written by its sponsor.


Apr 18, 2012

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 4384”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


1 cosponsors (1D) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 2295 (Related)
Patient Safety and Generic Labeling Improvement Act

Referred to Committee
Last Action: Apr 18, 2012

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: